Growth Hormone peptide fragment 176-191, also known as HGH Frag 176-191, is a modified form of amino acids 176-191 of the GH polypeptide. Investigators at Monash University discovered that the fat-reducing effects of GH appear to be controlled by a small region near one end of the Growth Hormone molecule. This region, which consists of amino acids 176-191, is less than 10% of the total size of the GH molecule and appears to have no effect on growth or insulin resistance.
Also known as Frag, HGH Frag 176-191, HGH Fragment 176 191 Growth Hormone peptide HGH Fragment 176-191 is a synthetic modified form of the GH polypeptide’s amino acids 176-191. Research carried out by scientists of the Monash University, revealed that the ability to reduce fat by GH was regulated by a small region close to the end of the GH Molecule. This small region contains amino acids 177-191, which makes up under 10 percent of the entire volume of the GH molecule. The region has no visible, effect on growth resistance or insulin resistance. The way it functions is by replicating how the Natural Growth Hormone regulates Fat metabolism, minus the harmful effects observed with unmodified Growth Hormone. Sequence: Tyr-Leu-Arg-Ile-Val-Gin-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe Molecular Formula: C78H123N23O13S2
This product is a lyophilized peptide for research use only. This product is NOT for human use and can be harmful if ingested. This product is for research/laboratory use only. This product is NOT to be injected. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and should not be misbranded, misused or mislabeled as a drug, food or cosmetic.
